|
US3885046A
(en)
*
|
1969-12-04 |
1975-05-20 |
Burroughs Wellcome Co |
Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression
|
|
US3885048A
(en)
*
|
1971-02-08 |
1975-05-20 |
James J Liggett |
Method for preparing simulated meat, fish and dairy products
|
|
US4361545A
(en)
|
1979-05-21 |
1982-11-30 |
Rowell Laboratories, Inc. |
Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion
|
|
US4882167A
(en)
|
1983-05-31 |
1989-11-21 |
Jang Choong Gook |
Dry direct compression compositions for controlled release dosage forms
|
|
USRE33994E
(en)
*
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
|
US4851229A
(en)
*
|
1983-12-01 |
1989-07-25 |
Alza Corporation |
Composition comprising a therapeutic agent and a modulating agent
|
|
DK62184D0
(da)
|
1984-02-10 |
1984-02-10 |
Benzon As Alfred |
Diffusionsovertrukket polydepotpraeparat
|
|
US5082655A
(en)
*
|
1984-07-23 |
1992-01-21 |
Zetachron, Inc. |
Pharmaceutical composition for drugs subject to supercooling
|
|
US4629621A
(en)
*
|
1984-07-23 |
1986-12-16 |
Zetachron, Inc. |
Erodible matrix for sustained release bioactive composition
|
|
US4769027A
(en)
*
|
1984-08-15 |
1988-09-06 |
Burroughs Wellcome Co. |
Delivery system
|
|
CA1239034A
(en)
|
1984-08-17 |
1988-07-12 |
Kelly L. Smith |
Delivery system
|
|
DE3672652D1
(de)
*
|
1985-03-29 |
1990-08-23 |
Shinko Electric Co Ltd |
Eisenbahnfahrzeug mit linearmotor.
|
|
US4797286A
(en)
*
|
1985-11-12 |
1989-01-10 |
Eli Lilly And Company |
Orally administerable sustained release pharmaceutical formulations
|
|
US4847092A
(en)
*
|
1985-11-12 |
1989-07-11 |
Eli Lilly And Company |
Orally administerable sustained release pharmaceutical formulations
|
|
IT1191674B
(it)
|
1986-03-07 |
1988-03-23 |
Eurand Spa |
Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
|
|
US4880622A
(en)
|
1986-05-20 |
1989-11-14 |
Research Corporation Technologies, Inc. |
Water-soluble phosphazene polymers having pharmacological applications
|
|
GB8613688D0
(en)
*
|
1986-06-05 |
1986-07-09 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
CH668553A5
(de)
*
|
1987-02-02 |
1989-01-13 |
Mepha Ag |
Arzneimittel mit verzoegerter wirkstofffreisetzung.
|
|
US5200193A
(en)
*
|
1987-04-22 |
1993-04-06 |
Mcneilab, Inc. |
Pharmaceutical sustained release matrix and process
|
|
US4837980A
(en)
*
|
1987-07-01 |
1989-06-13 |
The Uniroyal Goodrich Tire Company |
Method and apparatus for tire uniformity correction
|
|
US4792452A
(en)
|
1987-07-28 |
1988-12-20 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
US4795641A
(en)
*
|
1987-08-20 |
1989-01-03 |
Eastman Kodak Company |
Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
|
|
US5187150A
(en)
*
|
1987-10-14 |
1993-02-16 |
Debiopharm S.A. |
Polyester-based composition for the controlled release of polypeptide medicinal substances
|
|
JPH02257309A
(ja)
*
|
1989-03-30 |
1990-10-18 |
Fanuc Ltd |
Ｎｃプログラムの描画方法
|
|
US5030457A
(en)
*
|
1989-08-28 |
1991-07-09 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
EP0418596A3
(en)
*
|
1989-09-21 |
1991-10-23 |
American Cyanamid Company |
Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
|
|
GB2245559A
(en)
*
|
1990-06-25 |
1992-01-08 |
Farmos Oy |
Bioceramic system for delivery of a bioactive compound.
|
|
ES2067957T3
(es)
*
|
1990-08-07 |
1995-04-01 |
Pfizer |
Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
|
|
US5431922A
(en)
*
|
1991-03-05 |
1995-07-11 |
Bristol-Myers Squibb Company |
Method for administration of buspirone
|
|
US5169638A
(en)
|
1991-10-23 |
1992-12-08 |
E. R. Squibb & Sons, Inc. |
Buoyant controlled release powder formulation
|
|
US5582837A
(en)
|
1992-03-25 |
1996-12-10 |
Depomed, Inc. |
Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
|
|
ES2140458T3
(es)
*
|
1992-04-15 |
2000-03-01 |
Stanford Res Inst Int |
Aislamiento de esteroides que contienen una funcionalidad 5,7-dieno de una mezcla de esteroles.
|
|
GB9217295D0
(en)
*
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
DE59309257D1
(de)
*
|
1992-10-26 |
1999-02-11 |
Sanol Arznei Schwarz Gmbh |
Verfahren zur herstellung von mikrokapseln
|
|
DK0670717T3
(da)
*
|
1992-11-30 |
1999-08-09 |
Pfizer |
Leveringsanordninger med støttet væskemembran
|
|
US5656291A
(en)
*
|
1994-03-16 |
1997-08-12 |
Pharmacia & Upjohn Aktiebolag |
Controlled release preparation
|
|
SE9301057L
(sv)
*
|
1993-03-30 |
1994-10-01 |
Pharmacia Ab |
Beredning med kontrollerad frisättning
|
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US5541231A
(en)
*
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
US5523095A
(en)
*
|
1993-12-15 |
1996-06-04 |
Eastman Chemical Company |
Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
|
|
US5535556A
(en)
*
|
1994-04-18 |
1996-07-16 |
Hughes, Jr.; John P. |
Basement wall construction
|
|
US5567439A
(en)
*
|
1994-06-14 |
1996-10-22 |
Fuisz Technologies Ltd. |
Delivery of controlled-release systems(s)
|
|
US6020002A
(en)
*
|
1994-06-14 |
2000-02-01 |
Fuisz Technologies Ltd. |
Delivery of controlled-release system(s)
|
|
US5958458A
(en)
|
1994-06-15 |
1999-09-28 |
Dumex-Alpharma A/S |
Pharmaceutical multiple unit particulate formulation in the form of coated cores
|
|
US5478572A
(en)
|
1994-09-06 |
1995-12-26 |
Bristol-Myers Squibb Co. |
Gepirone dosage form
|
|
FR2725623A1
(fr)
*
|
1994-10-18 |
1996-04-19 |
Flamel Tech Sa |
Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
|
|
US5558879A
(en)
|
1995-04-28 |
1996-09-24 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water soluble drugs in which a passageway is formed in situ
|
|
US6558708B1
(en)
*
|
1995-05-17 |
2003-05-06 |
Cedars-Sinai Medical Center |
Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
|
|
US5654005A
(en)
*
|
1995-06-07 |
1997-08-05 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation having a preformed passageway
|
|
US6548084B2
(en)
*
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
|
CA2192782C
(en)
*
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
US5762961A
(en)
*
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
|
WO1997032573A1
(en)
|
1996-03-08 |
1997-09-12 |
Nycomed Danmark A/S |
Modified release multiple-units dosage composition
|
|
US6274171B1
(en)
*
|
1996-03-25 |
2001-08-14 |
American Home Products Corporation |
Extended release formulation of venlafaxine hydrochloride
|
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
|
FR2747921B1
(fr)
*
|
1996-04-24 |
1998-10-30 |
Adir |
Comprime matriciel permettant la liberation prolongee du sel de sodium de tianeptine apres administration par voie orale
|
|
HRP970493A2
(en)
*
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
|
ES2221019T3
(es)
|
1996-10-31 |
2004-12-16 |
Takeda Chemical Industries, Ltd. |
Preparacion de liberacion mantenida.
|
|
SI9600330A
(sl)
*
|
1996-11-11 |
1998-06-30 |
KEKO VARICON d.o.o. |
Zaščitna komponenta z več funkcijami
|
|
AU5609998A
(en)
*
|
1997-01-10 |
1998-08-03 |
Abbott Laboratories |
Tablet for the controlled release of active agents
|
|
CA2216215A1
(en)
|
1997-04-05 |
1998-10-05 |
Isa Odidi |
Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
|
|
US6641614B1
(en)
|
1997-05-01 |
2003-11-04 |
Spinal Concepts, Inc. |
Multi-variable-height fusion device
|
|
US6168873B1
(en)
|
1997-05-29 |
2001-01-02 |
Canon Kabushiki Kaisha |
Electrode substrate and recording medium
|
|
JP3950175B2
(ja)
|
1997-05-30 |
2007-07-25 |
オスモティカ・コーポレイション |
多層浸透デバイス
|
|
AU729529B2
(en)
*
|
1997-06-06 |
2001-02-01 |
Depomed, Inc. |
Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
|
|
EA002482B1
(ru)
*
|
1997-07-01 |
2002-06-27 |
Пфайзер Инк. |
Соли сертралина и лекарственные формы с длительным высвобождением сертралина
|
|
US6287587B2
(en)
|
1997-07-15 |
2001-09-11 |
Takeda Chemical Industries, Ltd. |
Process for producing sustained-release preparation by in-water drying
|
|
PT1003476E
(pt)
|
1997-08-11 |
2005-05-31 |
Alza Corp |
Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica
|
|
US5840334A
(en)
|
1997-08-20 |
1998-11-24 |
Fuisz Technologies Ltd. |
Self-binding shearform compositions
|
|
EP1017370B1
(en)
*
|
1997-09-11 |
2003-10-29 |
Nycomed Danmark ApS |
MODIFIED RELEASE MULTIPLE-UNITS COMPOSITIONS OF NON-STEROID ANTI-INFLAMMATORY DRUG SUBSTANCES (NSAIDs)
|
|
US6391336B1
(en)
*
|
1997-09-22 |
2002-05-21 |
Royer Biomedical, Inc. |
Inorganic-polymer complexes for the controlled release of compounds including medicinals
|
|
US6342250B1
(en)
*
|
1997-09-25 |
2002-01-29 |
Gel-Del Technologies, Inc. |
Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
|
|
US6197827B1
(en)
*
|
1997-10-03 |
2001-03-06 |
Cary Medical Corporation |
Nicotine addiction treatment
|
|
IT1297461B1
(it)
*
|
1997-10-29 |
1999-12-17 |
Ciocca Maurizio |
Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
|
|
US20030059471A1
(en)
*
|
1997-12-15 |
2003-03-27 |
Compton Bruce Jon |
Oral delivery formulation
|
|
US6221917B1
(en)
*
|
1997-12-30 |
2001-04-24 |
American Home Products Corporation |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
US5968553A
(en)
|
1997-12-30 |
1999-10-19 |
American Home Products Corporation |
Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer
|
|
US5919484A
(en)
*
|
1998-01-15 |
1999-07-06 |
Isp Investments Inc. |
Controlled release, drug-delivery tableted composition including a polymer of a vinyl amide, (meth)acrylic acid, a long chain alkyl (meth)acrylate and a lower alkyl (meth)acrylate
|
|
CA2318921A1
(en)
|
1998-01-29 |
1999-08-05 |
John R. Mccullough |
Pharmacological uses of optically pure (+)-bupropion
|
|
WO1999038499A2
(en)
|
1998-01-29 |
1999-08-05 |
Sepracor Inc. |
Methods and compositions for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
|
|
CA2318960A1
(en)
|
1998-01-29 |
1999-08-05 |
Sepracor Inc. |
Pharmaceutical uses of optically pure (+)-bupropion
|
|
JP4523153B2
(ja)
|
1998-03-19 |
2010-08-11 |
ブリストル−マイヤーズ スクイブ カンパニー |
易溶性薬物の二層性放出制御送達システムおよび方法
|
|
US6372254B1
(en)
*
|
1998-04-02 |
2002-04-16 |
Impax Pharmaceuticals Inc. |
Press coated, pulsatile drug delivery system suitable for oral administration
|
|
US6143325A
(en)
|
1998-06-05 |
2000-11-07 |
Bristol-Myers Squibb Company |
Nefazodone dosage form
|
|
US6153223A
(en)
*
|
1998-06-05 |
2000-11-28 |
Watson Pharmaceuticals, Inc. |
Stabilized pharmaceutical compositions
|
|
US6117452A
(en)
|
1998-08-12 |
2000-09-12 |
Fuisz Technologies Ltd. |
Fatty ester combinations
|
|
US6129931A
(en)
|
1998-09-03 |
2000-10-10 |
Isp Investments Inc. |
Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
|
|
ATE286725T1
(de)
*
|
1998-10-01 |
2005-01-15 |
Novartis Pharma Gmbh |
Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe
|
|
US6096341A
(en)
*
|
1998-10-30 |
2000-08-01 |
Pharma Pass Llc |
Delayed release tablet of bupropion hydrochloride
|
|
US6033686A
(en)
*
|
1998-10-30 |
2000-03-07 |
Pharma Pass Llc |
Controlled release tablet of bupropion hydrochloride
|
|
US6270805B1
(en)
*
|
1998-11-06 |
2001-08-07 |
Andrx Pharmaceuticals, Inc. |
Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate
|
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
|
HUP0104721A3
(en)
*
|
1998-12-17 |
2006-07-28 |
Alza Corp Mountain View |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
US6238697B1
(en)
*
|
1998-12-21 |
2001-05-29 |
Pharmalogix, Inc. |
Methods and formulations for making bupropion hydrochloride tablets using direct compression
|
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
|
US6342249B1
(en)
*
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6635281B2
(en)
|
1998-12-23 |
2003-10-21 |
Alza Corporation |
Gastric retaining oral liquid dosage form
|
|
CA2259730A1
(en)
|
1999-01-18 |
2000-07-18 |
Bernard Charles Sherman |
Sustained release tablets containing bupropion hydrochloride
|
|
US20030104048A1
(en)
*
|
1999-02-26 |
2003-06-05 |
Lipocine, Inc. |
Pharmaceutical dosage forms for highly hydrophilic materials
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6589553B2
(en)
*
|
2001-02-08 |
2003-07-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral dosage form
|
|
US6210716B1
(en)
*
|
1999-02-26 |
2001-04-03 |
Andrx Pharmaceuticals, Inc. |
Controlled release bupropion formulation
|
|
US8545880B2
(en)
*
|
1999-02-26 |
2013-10-01 |
Andrx Pharmaceuticals, Llc |
Controlled release oral dosage form
|
|
WO2000056311A1
(en)
*
|
1999-03-19 |
2000-09-28 |
Knoll Pharmaceutical Company |
Control of metabolism
|
|
FR2791809B1
(fr)
*
|
1999-04-01 |
2001-06-15 |
Air Liquide |
Procede et dispositif de traitement d'articles stockes dans des conteneurs et appareil de stockage dote d'un tel dispositif
|
|
JP2002541092A
(ja)
*
|
1999-04-06 |
2002-12-03 |
ファーマクエスト・リミテッド |
メチルフェニデートのパルス性送達のための薬学的投薬形態
|
|
US6116501A
(en)
|
1999-04-22 |
2000-09-12 |
The Procter & Gamble Company |
Stackable, self-supporting container with lid-alignment feature
|
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
FR2795326B1
(fr)
|
1999-06-28 |
2001-08-31 |
Adir |
Composition pharmaceutique solide thermoformable a liberation controlee
|
|
US6500459B1
(en)
*
|
1999-07-21 |
2002-12-31 |
Harinderpal Chhabra |
Controlled onset and sustained release dosage forms and the preparation thereof
|
|
US6387403B1
(en)
*
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
|
CA2324813A1
(en)
|
1999-11-10 |
2001-05-10 |
Susan Beth Sobolov-Jaynes |
Combination treatment for depression and anxiety
|
|
US6352721B1
(en)
*
|
2000-01-14 |
2002-03-05 |
Osmotica Corp. |
Combined diffusion/osmotic pumping drug delivery system
|
|
US7115297B2
(en)
*
|
2000-02-22 |
2006-10-03 |
Suzanne Jaffe Stillman |
Nutritionally fortified liquid composition with added value delivery systems/elements/additives
|
|
US6372252B1
(en)
*
|
2000-04-28 |
2002-04-16 |
Adams Laboratories, Inc. |
Guaifenesin sustained release formulation and tablets
|
|
US6306436B1
(en)
*
|
2000-04-28 |
2001-10-23 |
Teva Pharmaceuticals Usa, Inc. |
Stabilized, acid-free formulation for sustained release of bupropion hydrochloride
|
|
US20040156872A1
(en)
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
US6541532B1
(en)
*
|
2000-06-02 |
2003-04-01 |
Milliken & Company |
Scorch inhibiting compositions for polyurethane foams
|
|
US7678387B2
(en)
*
|
2000-06-06 |
2010-03-16 |
Capricorn Pharma, Inc. |
Drug delivery systems
|
|
US6488962B1
(en)
|
2000-06-20 |
2002-12-03 |
Depomed, Inc. |
Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
|
|
EP1313451B1
(en)
*
|
2000-08-31 |
2009-03-11 |
Jagotec AG |
Milled particles
|
|
US6540990B2
(en)
|
2000-09-22 |
2003-04-01 |
Gerard M. Nolan |
Physiological method of improving vision
|
|
US6491947B2
(en)
|
2000-11-03 |
2002-12-10 |
Chemlink Laboratories, Llc |
Expanded perborate salt, use, and method of production
|
|
CN1352938A
(zh)
*
|
2000-11-14 |
2002-06-12 |
北京万全阳光医药科技有限公司 |
盐酸安非他酮缓释片
|
|
CA2685214C
(en)
|
2001-02-08 |
2013-01-22 |
Andrx Pharmaceuticals, Inc. |
Improved controlled release oral dosage form
|
|
US20050031670A1
(en)
|
2001-05-22 |
2005-02-10 |
Jamerson Brenda Diane |
Weight reduction or weight controlling composition
|
|
US6960357B2
(en)
*
|
2001-05-25 |
2005-11-01 |
Mistral Pharma Inc. |
Chemical delivery device
|
|
DE10126163A1
(de)
|
2001-05-30 |
2002-12-05 |
Degussa |
Pharmazeutische Zubereitungen
|
|
ITMI20011457A1
(it)
*
|
2001-07-09 |
2003-01-09 |
Valpharma Sa |
Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva
|
|
US20030068356A1
(en)
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
|
US20030044462A1
(en)
*
|
2001-08-20 |
2003-03-06 |
Kali Laboratories, Inc. |
Sustained release tablets containing bupropion hydrochloride
|
|
US20030072802A1
(en)
*
|
2001-10-11 |
2003-04-17 |
R.T. Alamo Ventures, Inc. |
Sustained release topiramate
|
|
US6723340B2
(en)
*
|
2001-10-25 |
2004-04-20 |
Depomed, Inc. |
Optimal polymer mixtures for gastric retentive tablets
|
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
|
US20030091630A1
(en)
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
US7815936B2
(en)
*
|
2001-10-30 |
2010-10-19 |
Evonik Degussa Gmbh |
Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
JP2005516020A
(ja)
*
|
2001-12-20 |
2005-06-02 |
ファルマシア・コーポレーション |
ゼロ次持続放出剤形およびその製造方法
|
|
ATE357220T1
(de)
*
|
2002-01-09 |
2007-04-15 |
Ucb Farchim Sa |
Pharmazeutische zusammensetzung mit modifizierter freisetzung
|
|
DE10200813A1
(de)
|
2002-01-11 |
2003-09-18 |
Krauss Maffei Kunststofftech |
Spritzgießmaschine mit zumindest einer Säule
|
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
US7780987B2
(en)
*
|
2002-02-21 |
2010-08-24 |
Biovail Laboratories International Srl |
Controlled release dosage forms
|
|
IN192747B
(pt)
|
2002-04-15 |
2004-05-15 |
Ranbaxy Lab Ltd |
|
|
KR100483588B1
(ko)
*
|
2002-07-11 |
2005-04-18 |
주식회사 하이닉스반도체 |
난드형 플래시 메모리 소자의 셀렉트 라인 형성 방법
|
|
US20040115263A1
(en)
*
|
2002-08-26 |
2004-06-17 |
Robertson David W. |
Use of bupropion for treating restless legs syndrome
|
|
US6913768B2
(en)
*
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
|
US20040185097A1
(en)
|
2003-01-31 |
2004-09-23 |
Glenmark Pharmaceuticals Ltd. |
Controlled release modifying complex and pharmaceutical compositions thereof
|
|
BRPI0408999A
(pt)
*
|
2003-04-04 |
2006-03-28 |
Pharmacia Corp |
comprimidos prensados de multiparticulados de liberação oral prolongada
|
|
AR045423A1
(es)
|
2003-05-13 |
2005-10-26 |
Cephalon Inc |
Combinaciones de analiticos y antidepresivos
|